• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.67% Nasdaq Up1.47%

    Foundation Medicine, Inc. (FMI)

    -NasdaqGS
    35.76 Up 1.13(3.28%) May 27, 4:00PM EDT
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    FMIPVT1GHDXMYGNIndustry
    Market Cap:1.22BN/A883.71M2.38B105.57M
    Employees:293N/A7521,6491.10K
    Qtrly Rev Growth (yoy):0.93N/A0.02-0.020.00
    Revenue (ttm): 61.08MN/A276.86M721.98M3.80M
    Gross Margin (ttm):0.55N/A0.800.810.49
    EBITDA (ttm):-45.55MN/A-18.77M196.10M-1.90M
    Operating Margin (ttm): -0.87N/A-0.090.240.05
    Net Income (ttm):-52.22MN/A-26.64M95.12MN/A
    EPS (ttm):-1.87N/A-0.841.250.01
    P/E (ttm):N/AN/AN/A27.3534.55
    PEG (5 yr expected):N/AN/A-0.161.733.33
    P/S (ttm):16.51N/A3.113.339.40
     
    Pvt1 = Clarient, Inc. (privately held)
    GHDX = Genomic Health Inc.
    MYGN = Myriad Genetics Inc.
    Industry = Medical Laboratories & Research

     
    News on Direct Competitors 

    Currency in USD.